Tanja Andrea Gruber

This study tests a new treatment plan for infants under one year old with a type of leukemia. It adds an immunotherapy drug called blinatumomab to standard chemotherapy to try to wipe out any remaining leukemia cells. The goal is to see if this combination works better at clearin…